Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma

Journal of Liposome Research

Volumn 22, Issue 3, 2012, Pages 224-236

  Varshosaz, Jaleh ^a   Hassanzadeh, Farshid ^a   Sadeghi, Hojjat ^a   Khadem, Mostafa ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

5 FU; Asialoglycoprotein receptors; Galactosylated NLCs; Hepatocellular carcinoma; HepG2; Lactobionic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DECANOIC ACID; DRUG CARRIER; FLUOROURACIL; GALACTOSYLATED NANOSTRUCTURED LIPID CARRIER; GLYCEROL STEARATE; LABRAFAC; LACTOBIONIC ACID; NANOPARTICLE; OCTADECYLAMINE; OCTANOIC ACID; OLEIC ACID; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; PROPIDIUM IODIDE; SOLUTOL HS 15; SOY LECITHIN S100; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CELL STRAIN HEPG2; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONJUGATE; CONJUGATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFUSION; DRUG CYTOTOXICITY; EMULSION; ENCAPSULATION; FLOW CYTOMETRY; INFRARED SPECTROSCOPY; LIPOSOMAL DELIVERY; LIVER CELL CARCINOMA; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ZETA POTENTIAL;

ACETONE; AMINES; ANTINEOPLASTIC AGENTS; ASIALOGLYCOPROTEIN RECEPTOR; CARCINOMA, HEPATOCELLULAR; DELAYED-ACTION PREPARATIONS; DISACCHARIDES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; FLUOROURACIL; GALACTOSE; GLYCERIDES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; NANOPARTICLES; OLEIC ACID; PARTICLE SIZE; POLYSORBATES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TETRAZOLIUM SALTS; THIAZOLES; TOXICITY TESTS;

EID: 84865216743     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2012.662653     Document Type: Article

References (37)

1. Arias, J. L., Gallardo, V., Ruiz, M. A., Delgado, A. V. (2008). Magnetite/poly (alkylcyanoacrylate) (core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur J Pharm Biopharm 69:54-63.
2. Arias, J. L., Lopez-Viota, M., Delgado, A. V., Ruiz, M. A. (2010). Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting. Colloids Surf B Biointerfaces 77:111-116.
3. Chattopadhyay, N., Zastre, J., Wong, H. L., Wu, X. Y., Bendayan, R. (2008). Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res 25:2262-2271.
4. Fang, Y. P., Lin, Y. K., Su, Y. H., Fang, J. Y. (2011). Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core. Chem Pharm Bull 59:266-271.
5. Forner, A., Hessheimer, A. J., Real, M. I., Bruix, J. (2006). Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 60:89-98. (Pubitemid 44740494)
6. Han, F., Li, S., Yin, R., Liu, H., Xu, L. (2008). Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surfaces A Physicochem Eng Aspects315:210-216. (Pubitemid 350298857)
7. How, C. W., Abdullah, R., Abbasalipourkabir, R. (2011). Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80. Afr J Biotechnol 10:1684-1689.
8. F. Q., Jiang S. P., Du Y. Z., Yuan H., Ye Y. Q., Zeng S. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids and Surf B: Biointerf, 45(3-4):167-73. (Pubitemid 41415646)
9. Jenning, V., Thünemann, A. F., Gohla, S. H. (2000). Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199: 167-177. (Pubitemid 30236188)
10. Kim, J. H., Kim, Y. S., Kim, S., Park, J. H., Kim, K., Choi, K., et al. (2006). Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitxel. J Control Release 111:228-234. (Pubitemid 43290012)
11. Kim, T. H., Park, I. K., Nah, J. W., Choi, Y. J., Cho, C. S. (2004). Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials 25: 3783-3792. (Pubitemid 38327067)
12. Kuo, Y. C., Chung, J. F. (2011). Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf B Biointerfaces 83:299-306.
13. Lamprecht, A., Yamamoto, H., Takeuchi, H., Kawashima, Y. (2003). Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release 90:313-322. (Pubitemid 36859963)
14. Lin, X., Li, X., Zheng, L. Q., Yu, L., Zhang, Q., Liu, W. (2007). Preparation and characterization of monocaprate nanostructured lipid carriers. Colloid Surf A: Physicochem Eng Asp 311: 106-111. (Pubitemid 350026290)
15. Llovet, J. M., Burroughs, A., Bruix, J. (2003). Hepatocellular carcinoma. The Lancet 362:1907-1917. (Pubitemid 37518510)
16. Managit, C., Kawakami, S., Yamashita, F., Hashida, M. (2005). Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells. Int J Pharm 301:255-261. (Pubitemid 41206610)
17. Memisoglu-Bilensoy, E., Do?an, A. L., Hincal, A. A. (2006). Cytotoxic evaluation of injectable cyclodextrin nanoparticles. J Pharm Pharmacol 58:585-589.
18. Rejinold, N. S., Muthunarayanan, M., Chennazhi, K. P., Nair, S. V., Jayakumar, R. (2011). 5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int J Biolog Macromol 48:98-105.
19. Saupe, A., Gordon, K. C., Rades, T. (2006). Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 314: 56-62.
20. Shen, J., Sun, M., Ping, Q., Ying, Z., Liu, W. (2010). Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology 21:025101.
21. Soo, P. L., Dunne, M., Liu, J., Allen, C. (2009). Nano-sized advanced delivery systems as parenteral formulation strategies for hydrophobic anti-cancer drugs. In: Nanotechnology in drug delivery (pp. 349-383.) New York: Springer Science/AAPS
22. Su, Z., Niu, J., Xiao, Y., Ping, Q., Sun, M., Huang, A., et al. (2011). Effect of octreotide-polyethylene glycol (100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Mol Pharm 8: 1641-1651.
23. Teeranachaideekul, V., Müller, R. H., Junyaprasert, V. B. (2007). Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-effects of formulation parameters on physicochemical stability. Int J Pharm 340: 198-206. (Pubitemid 47049784)
24. Terada, T., Iwai, M., Kawakami, S., Yamashita, F., Hashida, M. (2006). Novel PEG-matrix metalloproteinase-2 cleavable peptidelipid containinggalactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release 111: 333-342.
25. Wang, S. N., Deng, Y. H., Xu, H., Wu, H. B., Qiu, Y. K., Chen, D. W. (2006). Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm 62:32-38. (Pubitemid 41736022)
26. Wang, W., Zhao, X., Hu, H., Chen, D., Gu, J., Deng, Y., et al. (2010). Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability. Drug Deliv 17:114-122.
27. Wu, D. Q., Lu, B., Chang, C., Chen, C. S., Wang, T., Zhang, Y. Y., et al. (2009). Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterals 30:1363-1371.
28. Wu, J., Zern, M. A. (1996). Modification of liposomes for liver targeting. J Hepatol 24:757-763. (Pubitemid 26226674)
29. Xu, Z., Chen, L., Gu, W., Gao, Y., Lin, L., Zhang, Z, et al. (2009). The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterals 30: 226-232.
30. Yamaguchi, F., Kamitori, K., Sanada, K., Horii, M., Dong, Y., Sui, L., et al. (2008). Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7. J Biosci Bioeng 106:248-252.
31. Yuan, F., Qin, X., Zhou, D., Xiang, Q. Y., Wang, M. T., Zhang, Z. R., et al. (2008). In vitro cytotoxicity, in vivo biodistribution, and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. Eur J Pharm Biopharm 70:770-776.
32. Yuan, H., Wang, L. L., Du, Y. Z., You, J., Hu, F. Q., Zeng, S. (2007). Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloid Surf B Biointerfaces 60:174-179. (Pubitemid 350030429)
33. Zhang, X. G., Miao, J., Dai, Y. Q., Du, Y. Z., Yuan, H., Hu, F. Q. (2008). Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 361:239-244.
34. Zhang, Y., Li, J., Lang, M., Tang, X., Li, L., Shen, X. (2011). Folatefunctionalized nanoparticles for controlled 5-fluorouracil delivery. J Colloid Interface Sci 354:202-209.
35. Zheng, Y., Yang, W., Wang, C., Hu, J., Fu, S., Dong, L., et al. (2007). Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization, and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm 67:621-631. (Pubitemid 47576611)
36. Zhu, L., Ma, J., Jia, N., Zhao, Y., Shen, H. (2009). Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization, and cytotoxicity studies. Colloids Surf B Biointerfaces 68:1-6.
37. Zimmermann, E., Souto, E. B., Muller, R. H. (2005). Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR. Pharmazie 60:508-513. (Pubitemid 41025565)